PATENT CLAIM ANALYSIS

Application Number: 15980778
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["544", "106000"]

Abstract:
The invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Claim (Index 19):
A compound according to  claim 13 , wherein R 2  and R 3 , together with the nitrogen atom to which they are attached, are linked to form a 6-membered heterocyclyl wherein the 6-membered heterocyclyl contains a further nitrogen atom.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 93.0
- Lexical Diversity: 1.28
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12994246', '13254034', '12994250', '16073355', '12994253']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8096377297428811
- 35 USC 102 Novelty (BERT): 0.5517601026023651
- Combined Prediction Score: 0.7838499670288295
- Mean Citation Score: 410.43912599999993
- Max Citation Score: 422.44675
- Similarity Product: 304.6045845654905

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test